Adalimumab Plus Methotrexate Promising for Psoriasis
The efficacy, safety, pharmacokinetics, and immunogenicity of adalimumab combined with MTX compared with that adalimumab in patients with chronic plaque psoriasis is evaluated.
Diagnosis & Disease Information
Improved Outcomes With Holistic Approaches to Dermatology
Dermatologists are well positioned to recognize the signs of systemic disease, explains Torunn Sivesind, MD, a dermatology fellow at the University of Colorado Anschutz Medical Campus in Colorado.
- Loading...
Loading...
Next post in News
Loading... 
Loading...